Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Int J Immunogenet ; 36(3): 193-5, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19490216

RESUMEN

CTLA4 genetic polymorphisms have been associated with type 1 diabetes. We genotyped 207 patients and 249 controls for the most frequently investigated polymorphism of the CTLA4 gene (+49A/G (rs231775)). No significant differences were observed, suggesting that this polymorphism is not strongly associated with type 1 diabetes in the Portuguese population.


Asunto(s)
Antígenos CD/genética , Diabetes Mellitus Tipo 1/genética , Frecuencia de los Genes/genética , Adolescente , Adulto , Antígeno CTLA-4 , Estudios de Casos y Controles , Diabetes Mellitus Tipo 1/epidemiología , Femenino , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Masculino , Polimorfismo de Nucleótido Simple , Portugal/epidemiología , Estudios Retrospectivos , Adulto Joven
2.
Magn Reson Med ; 60(3): 517-23, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18727053

RESUMEN

The contribution of gluconeogenesis to hepatic glucose production (GP) was quantified after (2)H(2)O ingestion by Bayesian analysis of the position 2 and 5 (2)H-NMR signals (H2 and H5) of monoacetone glucose (MAG) derived from urinary acetaminophen glucuronide. Six controls and 10 kidney transplant (KTx) patients with cyclosporine A (CsA) immunosuppressant therapy were studied. Seven KTx patients were lean and euglycemic (BMI = 24.3 +/- 1.0 kg/m(2); fasting glucose = 4.7 +/- 0.1 mM) while three were obese and hyperglycemic (BMI = 30.5 +/- 0.7 kg/m(2); fasting glucose = 7.1 +/- 0.5 mM). For the 16 spectra analyzed, the mean coefficient of variation for the gluconeogenesis contribution was 10% +/- 5%. This uncertainty was associated with a mean signal-to-noise ratio (SNR) of 79:1 and 45:1 for the MAG H2 and H5 signals, respectively. For control subjects, gluconeogenesis contributed 54% +/- 7% of GP as determined by the mean and standard deviation (SD) of individual Bayesian analyses. For the lean/normoglycemic KTx subjects, the gluconeogenic contribution to GP was 62% +/- 7% (P = 0.06 vs. controls), while hyperglycemic/obese KTx patients had a gluconeogenic contribution of 68% +/- 3% (P < 0.005 vs. controls). These data suggest that in KTx patients, an increased gluconeogenic contribution to GP is strongly associated with obesity and hyperglycemia.


Asunto(s)
Glucemia/biosíntesis , Óxido de Deuterio/metabolismo , Deuterio/análisis , Glucurónidos/metabolismo , Trasplante de Riñón/efectos adversos , Adulto , Teorema de Bayes , Agua Corporal/metabolismo , Estudios de Casos y Controles , Óxido de Deuterio/administración & dosificación , Diabetes Mellitus/etiología , Femenino , Glucurónidos/orina , Humanos , Glucógeno Hepático/sangre , Glucógeno Hepático/metabolismo , Masculino , Persona de Mediana Edad , Estándares de Referencia , Adulto Joven
3.
Acta Med Port ; 15(4): 311-3, 2002.
Artículo en Portugués | MEDLINE | ID: mdl-12525025

RESUMEN

We review the pathophysiology, clinical features and therapy of acute thyroiditis. Four cases are reported stressing the role of fine needle aspiration for the diagnosis of this clinical entity.


Asunto(s)
Tiroiditis , Enfermedad Aguda , Adulto , Anciano , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tiroiditis/diagnóstico , Tiroiditis/terapia
4.
Ann Ist Super Sanita ; 33(3): 367-70, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9580366

RESUMEN

An insulin-modified frequently sampled intravenous glucose tolerance test with minimal model analysis was performed in normal pregnant women between 28-32 weeks of gestation, to assess insulin sensitivity and insulin secretion. Insulin sensitivity in the pregnant group (no. 26) was reduced to approximately 50% that of nonpregnant group (no. 27) (p < 0.05). This increased insulin resistance was compensated by an enhancement of the first phase of insulin secretion, which was increased more than twofold in the pregnant women when compared with the nonpregnant women (p < 0.05). There was a trend toward greater insulin resistance and insulin secretion in the obese pregnant women (no. 7) as compared with the lean pregnant women (no. 19) although this difference was not statistically significant. Our findings confirm that late pregnancy is a state of physiologic insulin resistance compensated by an increase of insulin secretion.


Asunto(s)
Resistencia a la Insulina/fisiología , Insulina/metabolismo , Obesidad/metabolismo , Complicaciones del Embarazo/metabolismo , Adulto , Peso Corporal/fisiología , Femenino , Humanos , Embarazo , Valores de Referencia
5.
Acta Med Port ; 8 Suppl 1: S41-5, 1995 Jun.
Artículo en Portugués | MEDLINE | ID: mdl-7653305

RESUMEN

The AA. report on their very limited experience with whole pancreatic transplantation. For the moment this is the only experience in Portugal, the detailed report of the 3 cases may be of some help to other Portuguese groups interested in starting this therapeutical approach for insulin-dependent end-stage renal failure patients. The main comments focus on the third simultaneous pancreas-kidney transplantation, which failed for technical reasons, mainly related to less than good selection of both donor and recipient. In all the three cases the technique preferred was the duodenocystostomy. The 2 first cases are doing very well, free of insulin and with normal glucose metabolism, at 15 and 7 months after grafting. The AA. also make some considerations on the indications, complications and follow-up of patients with pancreas-kidney transplantation.


Asunto(s)
Trasplante de Páncreas , Adulto , Cadáver , Colecistostomía , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 1/cirugía , Nefropatías Diabéticas/complicaciones , Nefropatías Diabéticas/cirugía , Duodenostomía , Femenino , Humanos , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/cirugía , Trasplante de Riñón , Masculino , Trasplante de Páncreas/métodos , Complicaciones Posoperatorias/epidemiología
6.
Acta Med Port ; 4(2): 76-8, 1991.
Artículo en Portugués | MEDLINE | ID: mdl-1867120

RESUMEN

The aim of the study was to assess, in patients with non insulin dependent diabetes mellitus (NIDDM), either with previous failure to sulphonylureas or insulin treated since the disease started, if the combination of gliclazide to insulin therapy might induce a reduction of daily insulin requirement. 30 caucasian type II patients used to self-monitoring (11 female, 19 male, mean age 55.78 +/- 8.07) with residual pancreatic function (glucagon induced C-peptide release = 1.01 +/- 0.70 microgram/ml) entered the study. 8 were excluded for non compliance or for high antiinsulin antibodies levels and 4 are still under study. Each patients was given, for 3 months, 240 mg of gliclazide in addition to usual daily dose of insulin. Data presented as mean +/- s.e.m. were analysed with analysis of variance (p less than 0.05). Mean initial values of main parameters were as follows: glycaemia 192.7 +/- 33.1 mg/100 ml, insulinaemia 9.5 +/- 4.5 microUI/ml, daily insulin requirements 33.11 +/- 10.47 U/d, HbA1 C 7.5 +/- 1.7%. Total cholesterol 240.1 +/- 52.2 mg/10 ml, triglycerides 120.6 +/- 60.3 mg/100 ml. After 3 months treatment significant reduction in mean daily insulin requirements (20.78 +/- 16.15 U/d) was observed. In 13 patients (72.2%) while keeping good metabolic control (HbA1 C 7.46 +/- 1.63), insulin therapy was reduced (9 patients) or even stopped (4 patients). In the other 5, insulin was maintained or slightly increased. The increase in glucagon induced C-peptide release (1.41 +/- 0.99 micrograms/ml) did not reach significance, while glycaemia and insulinaemia were not changed (196.0 +/- 34.1 mg/100 ml, 11.02 +/- 5.05 microUI/ml).(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Gliclazida/uso terapéutico , Insulina/uso terapéutico , Quimioterapia Combinada , Femenino , Gliclazida/administración & dosificación , Humanos , Insulina/administración & dosificación , Masculino , Persona de Mediana Edad
7.
Acta Med Port ; 3(4): 235-9, 1990.
Artículo en Portugués | MEDLINE | ID: mdl-2275415

RESUMEN

The authors have elaborated a statistic survey about the pregnant women with endocrinopathies, that they have examined in the outpatient clinic from January of 1980 to December of 1988. Three hundred and twenty four women were examined in an amount of 2152 (two thousand one hundred and fifty two) observations. The incidence for 100 births was 0.54%. Maternal and fetal mobility and mortality were analysed in correlation with the maternal area of endocrinopathy (Diabetes Mellitus, Thyroid, Hypophysis and Adrenal Glands) and with the necessary therapeutic regimens. At last the A.A. made some considerations about the importance of a team approach in this area of medical care, and applied to the clinicians who work in primary care, to a better collaboration.


Asunto(s)
Servicio Ambulatorio en Hospital/estadística & datos numéricos , Enfermedades de la Hipófisis/epidemiología , Complicaciones del Embarazo/epidemiología , Embarazo en Diabéticas/epidemiología , Enfermedades de la Tiroides/epidemiología , Endocrinología , Femenino , Enfermedades Fetales/epidemiología , Hospitales Universitarios/estadística & datos numéricos , Humanos , Obstetricia , Enfermedades de la Hipófisis/terapia , Portugal , Embarazo , Complicaciones del Embarazo/terapia , Embarazo en Diabéticas/terapia , Enfermedades de la Tiroides/terapia
8.
Acta Med Port ; Suppl 1: 25S-26S, 1989 Sep.
Artículo en Portugués | MEDLINE | ID: mdl-2694771

RESUMEN

With near optimal metabolic control, in diabetes mellitus, hypoglycaemia has become a very important problem. Its main causes are excessive insulin or sulfonylurea dosages, omission of meals, unprogrammed physical exercise or disturbances of the neurohormonal counterregulatory mechanisms.


Asunto(s)
Hipoglucemia/etiología , Insulina/efectos adversos , Diabetes Mellitus/tratamiento farmacológico , Humanos , Hipoglucemia/inducido químicamente , Hipoglucemia/fisiopatología , Insulina/uso terapéutico , Compuestos de Sulfonilurea/efectos adversos , Compuestos de Sulfonilurea/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA